Altenburg, A., Badawy, A. M., Nikolakis, G., Wild, T., & Wojtalewicz, N. (2016). CD40/CD40 ligand interactions and TNFб treatment reduce activity of P105 promoter of the human papilloma virus-18 in vitro.
Chicago Style (17th ed.) CitationAltenburg, A., Abdel-Naser M. Badawy, G. Nikolakis, T. Wild, and N. Wojtalewicz. CD40/CD40 Ligand Interactions and TNFб Treatment Reduce Activity of P105 Promoter of the Human Papilloma Virus-18 in Vitro. 2016.
MLA (8th ed.) CitationAltenburg, A., et al. CD40/CD40 Ligand Interactions and TNFб Treatment Reduce Activity of P105 Promoter of the Human Papilloma Virus-18 in Vitro. 2016.
Warning: These citations may not always be 100% accurate.